Search results
Results from the WOW.Com Content Network
Transitional cell carcinoma is a type of cancer that arises from the transitional epithelium, a tissue lining the inner surface of these hollow organs. [1] It typically occurs in the urothelium of the urinary system; in that case, it is also called urothelial carcinoma.
Invasive urothelial carcinoma is a type of transitional cell carcinoma. It is a type of cancer that develops in the urinary system: the kidney , urinary bladder , and accessory organs. Transitional cell carcinoma is the most common type of bladder cancer and cancer of the ureter , urethra , renal pelvis , the ureters , the bladder , and parts ...
After surgery to remove the tumor, a single dose of chemotherapy injected into the bladder is helpful in reducing the rate of cancer recurrence in people who have cancer of the inner lining of the bladder (upper tract urothelial carcinoma). [12] Serious side effects don't seem to be increased by chemotherapy. [12]
Bladder cancer prognosis varies based on how widespread the cancer is at the time of diagnosis. For those with tumors confined to the innermost layer of the bladder (stage 0 disease), 96% are still alive five years from diagnosis. Those whose tumors have spread to nearby lymph nodes (stage 3 disease) have worse prognoses; 36% survive at least ...
Urethral cancer is a rare cancer originating from the urethra. The disease has been classified by the TNM staging system and the World Health Organization. [1] [3] [4] Symptoms include blood in the urine, lump at end of penis, or bloody penile discharge. [2] Diagnosis is established by transurethral biopsy. [1]
Papillary urothelial neoplasm of low malignant potential (PUNLMP) is an exophytic (outward growing), (microscopically) nipple-shaped (or papillary) pre-malignant growth of the lining of the upper genitourinary tract (the urothelium), which includes the renal pelvis, ureters, urinary bladder and part of the urethra.
Urachal cancer is a very rare type of cancer arising from the urachus or its remnants. [1] The disease might arise from metaplastic glandular epithelium or embryonic epithelial remnants originating from the cloaca region. [2] It occurs in roughly about one person per 1 million people per year varying on the geographical region. [3]
After the cancer is staged, treatment may involve open surgery to remove the affected ureter and kidney if it is involved; or, if the lesion is small, it may be removed via ureteroscopy. [18] Prognosis can vary markedly depending on the tumour grade, with a worse prognosis associated with an ulcerating lesion. [18]